Biljana Horn, MD - Research

Research at a glance

Top areas of exploration

Hematopoietic Stem Cell Transplantation , 34 publications
Graft vs Host Disease , 12 publications
Transplantation Conditioning , 11 publications
Transplantation, Homologous , 10 publications

Research activity

60 publications

1,620 citations

Why is this important?

Active clinical trials

BMT12108, Non-Myeloablative Conditioning and Bone Marrow Transplantation

Allogeneic blood or marrow transplantation (alloBMT) is a curative therapy for a variety of hematologic disorders, including sickle cell disease and thalassemia. Even when it is clear that alloBMT can give to these patients an improvement in their鈥�

Investigators: Jordan Milner, Biljana Horn
Status: Accepting Candidates
Ages: 1 Year - 70 Years
Sexes: All

Conditioning SCID Infants Diagnosed Early (CSIDE)

The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of complications after transplantation. This trial identifies babies with types of immune鈥�

Investigators: Jordan Milner, Biljana Horn
Status: Accepting Candidates
Ages: 0 Years - 2 Years
Sexes: All

My publications

60 publications

2019

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

Bone marrow transplantation

鈥�

2018

KRAB-ZFP Repressors Enforce Quiescence of Oncogenic Human Herpesviruses.

Journal of virology

鈥�

2017

Early mixed chimerism-based preemptive immunotherapy in children undergoing allogeneic hematopoietic stem cell transplantation for acute leukemia.

Pediatric blood & cancer

鈥�

2017

Evaluation of Pre-Hematopoietic Cell Transplantation (HCT) Brain MRI and Neurologic Complications of Pediatric Patients Undergoing HCT for Hematologic Malignancies.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

鈥�

2017

Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies.

Bone marrow transplantation

鈥�

网红黑料

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.

KRAB-ZFP Repressors Enforce Quiescence of Oncogenic Human Herpesviruses.

Early mixed chimerism-based preemptive immunotherapy in children undergoing allogeneic hematopoietic stem cell transplantation for acute leukemia.

Evaluation of Pre-Hematopoietic Cell Transplantation (HCT) Brain MRI and Neurologic Complications of Pediatric Patients Undergoing HCT for Hematologic Malignancies.

Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies.